Through tetramer staining, we demonstrated activation and expansion of both NKT and peptide‐specific CD8+ T cells, and via the use of glycolipid‐only, irrelevant‐peptide controls, and depletion of CD8+ T cells, we show this tumor protection is peptide‐specific. This evidence concerns the gene CD8A and neoplasm.